Clinical Trials Browser

Phase 3 × Completed × Sunitinib × Clear all

NCT02853331 2026-02-02

KEYNOTE-426

Phase 3 Completed

861 enrolled 24 charts 1 FDA

Carcinoma, Renal Cell

NCT04394975 2025-11-28

Study to Evaluate the Efficacy and Safety of Toripalimab in Combination With Axitinib Versus Sunitinib Monotherapy in Advanced Renal Cell Cancer

Phase 3 Completed

Primary Disease: Unresectable or Metastatic Renal Cell Carcinoma Focus of the Study:PFS Assessed by IRC Per RECIST 1.1

NCT00930033 2025-09-05

CARMENA

Phase 3 Completed

Carcinoma, Renal Cell

NCT02684006 2025-07-30

JAVELIN Renal 101

Phase 3 Completed

886 enrolled 37 charts 1 FDA

Carcinoma, Renal Cell, Kidney Diseases, Kidney Neoplasms, Neoplasms

NCT03260894 2025-07-29

Pembrolizumab (MK-3475) Plus Epacadostat vs Standard of Care in mRCC (KEYNOTE-679/ECHO-302)

Phase 3 Completed

129 enrolled 13 charts

Parkinson Disease 4, Autosomal Dominant Lewy Body, Carcinoma, Renal Cell

NCT02231749 2025-06-26

Nivolumab Combined With Ipilimumab Versus Sunitinib in Previously Untreated Advanced or Metastatic Renal Cell Carcinoma (CheckMate 214)

Phase 3 Completed

1,390 enrolled 18 charts 1 FDA

Carcinoma, Renal Cell

NCT00720941 2025-03-30

COMPARZ

Phase 3 Completed

1,110 enrolled 27 charts

Carcinoma, Renal Cell

NCT02420821 2023-01-30

IMmotion151

Phase 3 Completed

915 enrolled 40 charts

Carcinoma, Renal Cell

NCT01694277 2020-12-08

Masitinib in Patients With Gastrointestinal Stromal Tumour After Progression With Imatinib

Phase 3 Completed

GastrointestinalSarcoma

Neoplasm Metastasis, Gastrointestinal Stromal Tumors

NCT00375674 2018-09-21

S-TRAC

Phase 3 Completed

674 enrolled 19 charts 1 FDA

Kidney Neoplasms

NCT01265901 2017-10-12

IMA901 in Patients Receiving Sunitinib for Advanced/Metastatic Renal Cell Carcinoma

Phase 3 Completed

Carcinoma, Renal Cell

NCT01064310 2017-04-17

PISCES

Phase 3 Completed

169 enrolled 16 charts

Carcinoma, Renal Cell, Neoplasms, Patient Preference

NCT00457691 2015-03-30

Study Of FOLFIRI Chemotherapy With Or Without Sunitinib In Patients With Metastatic Colorectal Cancer

Phase 3 Completed

768 enrolled 15 charts

Gastrointestinal

Colorectal Neoplasms

NCT00457392 2013-10-29

A Study In Patients With Non-Small Cell Lung Cancer To Test If Erlotinib Plus SU011248 Is Better Than Erlotinib Alone

Phase 3 Completed

960 enrolled 13 charts

Carcinoma, Non-Small-Cell Lung

NCT00393939 2012-07-19

SUN 1064

Phase 3 Completed

594 enrolled 11 charts

Breast Neoplasms

NCT00435409 2012-06-26

A Study Of Sunitinib In Combination With Capecitabine Compared With Capecitabine In Patients With Breast Cancer

Phase 3 Completed

442 enrolled 12 charts

Breast Neoplasms

NCT00471328 2012-06-12

ENEST

Phase 3 Completed

248 enrolled 17 charts

GastrointestinalSarcoma

Gastrointestinal Stromal Tumors

NCT00083889 2010-01-26

SU011248 Versus Interferon-Alfa As First-Line Systemic Therapy For Patients With Metastatic Renal Cell Carcinoma

Phase 3 Completed

750 enrolled 20 charts

Carcinoma, Renal Cell

NCT00075218 2009-09-28

A Study To Assess The Safety And Efficacy Of SU11248 In Patients With Gastrointestinal Stromal Tumor(GIST)

Phase 3 Completed

361 enrolled 23 charts

GastrointestinalSarcoma

Gastrointestinal Stromal Tumors